322 related articles for article (PubMed ID: 26916161)
1. Humoral Response in Liver Allograft Transplantation: A Review of the Role of Anti-Human Leukocyte Antigen (HLA) Antibodies.
Muro M; Moya-Quiles MR; Mrowiec A
Curr Protein Pept Sci; 2016; 17(8):776-784. PubMed ID: 26916161
[TBL] [Abstract][Full Text] [Related]
2. Antibody-mediated rejection in the liver allograft.
Hübscher SG
Curr Opin Organ Transplant; 2012 Jun; 17(3):280-6. PubMed ID: 22569512
[TBL] [Abstract][Full Text] [Related]
3. Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation.
Salah A; Fujimoto M; Yoshizawa A; Yurugi K; Miyagawa-Hayashino A; Sumiyoshi S; Minamiguchi S; Uemoto S; Maekawa T; Haga H
Liver Transpl; 2014 Feb; 20(2):200-9. PubMed ID: 24470446
[TBL] [Abstract][Full Text] [Related]
4. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
Ali S; Ormsby A; Shah V; Segovia MC; Kantz KL; Skorupski S; Eisenbrey AB; Mahan M; Huang MA
Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
[TBL] [Abstract][Full Text] [Related]
5. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
[TBL] [Abstract][Full Text] [Related]
6. Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss.
O'Leary JG; Kaneku H; Demetris AJ; Marr JD; Shiller SM; Susskind BM; Tillery GW; Terasaki PI; Klintmalm GB
Liver Transpl; 2014 Feb; 20(2):218-27. PubMed ID: 24382837
[TBL] [Abstract][Full Text] [Related]
7. Immune response and histology of humoral rejection in kidney transplantation.
González-Molina M; Ruiz-Esteban P; Caballero A; Burgos D; Cabello M; Leon M; Fuentes L; Hernandez D
Nefrologia; 2016; 36(4):354-67. PubMed ID: 27267916
[TBL] [Abstract][Full Text] [Related]
8. Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts.
Miyagawa-Hayashino A; Yoshizawa A; Uchida Y; Egawa H; Yurugi K; Masuda S; Minamiguchi S; Maekawa T; Uemoto S; Haga H
Liver Transpl; 2012 Nov; 18(11):1333-42. PubMed ID: 22888064
[TBL] [Abstract][Full Text] [Related]
9. Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts.
OʼLeary JG; Demetris AJ; Philippe A; Freeman R; Cai J; Heidecke H; Smith C; Hart B; Jennings LW; Catar R; Everly M; Klintmalm GB; Dragun D
Transplantation; 2017 Oct; 101(10):2399-2409. PubMed ID: 28665894
[TBL] [Abstract][Full Text] [Related]
10. Influence of preformed donor-specific antibodies and C4d on early liver allograft function.
Perera MT; Silva MA; Murphy N; Briggs D; Mirza DF; Neil DA
Scand J Gastroenterol; 2013 Dec; 48(12):1444-51. PubMed ID: 24131305
[TBL] [Abstract][Full Text] [Related]
11. Antibody-mediated rejection in pediatric liver transplant recipients.
Markiewicz-Kijewska M; Kaliciński P; Kluge P; Piątosa B; Rękawek A; Jankowska I; Kostecka E; Kurowski PN
Ann Transplant; 2014 Mar; 19():119-23. PubMed ID: 24594760
[TBL] [Abstract][Full Text] [Related]
12. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
[TBL] [Abstract][Full Text] [Related]
13. Antibody-Mediated Rejection After Liver Transplant.
Lee M
Gastroenterol Clin North Am; 2017 Jun; 46(2):297-309. PubMed ID: 28506366
[TBL] [Abstract][Full Text] [Related]
14. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.
Musat AI; Agni RM; Wai PY; Pirsch JD; Lorentzen DF; Powell A; Leverson GE; Bellingham JM; Fernandez LA; Foley DP; Mezrich JD; D'Alessandro AM; Lucey MR
Am J Transplant; 2011 Mar; 11(3):500-10. PubMed ID: 21342448
[TBL] [Abstract][Full Text] [Related]
15. Beyond C4d: the ultrastructural appearances of endothelium in ABO-incompatible renal allografts.
Bröcker V; Pfaffenbach A; Habicht A; Chatzikyrkou C; Kreipe HH; Haller H; Scheffner I; Gwinner W; Zilian E; Immenschuh S; Schwarz A; Horn PA; Heinemann FM; Becker JU
Nephrol Dial Transplant; 2013 Dec; 28(12):3101-9. PubMed ID: 24081856
[TBL] [Abstract][Full Text] [Related]
16. Acute antibody-mediated rejection after lung transplantation.
Witt CA; Gaut JP; Yusen RD; Byers DE; Iuppa JA; Bennett Bain K; Alexander Patterson G; Mohanakumar T; Trulock EP; Hachem RR
J Heart Lung Transplant; 2013 Oct; 32(10):1034-40. PubMed ID: 23953920
[TBL] [Abstract][Full Text] [Related]
17. Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: diagnostic considerations in the evaluation of liver allografts.
Kozlowski T; Andreoni K; Schmitz J; Hayashi PH; Nickeleit V
Liver Transpl; 2012 Jun; 18(6):641-58. PubMed ID: 22298469
[TBL] [Abstract][Full Text] [Related]
18. Circulating donor-specific anti-human leukocyte antigen antibodies and complement C4d deposition are associated with the development of cardiac allograft vasculopathy.
Frank R; Molina MR; Goldberg LR; Wald JW; Kamoun M; Lal P
Am J Clin Pathol; 2014 Dec; 142(6):809-15. PubMed ID: 25389335
[TBL] [Abstract][Full Text] [Related]
19. C4d-negative antibody-mediated rejection in renal allografts: evidence for its existence and effect on graft survival.
Haas M
Clin Nephrol; 2011 Apr; 75(4):271-8. PubMed ID: 21426880
[TBL] [Abstract][Full Text] [Related]
20. Clinical and pathological analyses of transplant glomerulopathy cases.
Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]